We are happy to tell you that HCS Pharma, SMMiL-E team (Seeding Microsystems in Medecine in Lille – European-Japanese Technologies against Cancer, CNRS UMI-2820 LIMMS/IIS) and Institut d’Electronique, de Micro-Electronique et de Nanotechnologie (IEMN) have successfully applied to a LabCom grant (‘COMmon LABoratory’)! A LabCom aims at gathering two entities Read more…
Elodie is waiting for you on the first floor at Nutr’event 2019! HCS Pharma stand is n° D6/2, on Clubster NHL pavilion. She will be glad to discuss with you about: our in vitro tests for the objectivation of your claims on human cells (e.g. nutraceutical, dermocosmetic claims) our innovative Read more…
It was a great pleasure to be invited (thanks to our partner Molecular Devices) to present our work during these 2 events organized by selectBio in Rotterdam: Organoids and Tox Screening Europe 2019 on June 13-14 Organ-on-a-Chip and Tissue-on-a-Chip Europe 2019 on June 18-19 Both were of great interest for Read more…
We will be present this week and next week in Rotterdam, to talk about 3D cell culture and the importance of the microenvironnement in the relevance of in vitro models. As you known, to mimic human tissues, several parameters need to be taken into account: the target cells, nutrient intake Read more…
Last week we had the pleasure to attend the first SLAS Europe (Society for Laboratory Automation and Screening) meeting, which took place in the great Brussels Square meeting centre (Belgium) between the 27th and the 29th of June. Bringing together more than 1,000 academic and industry scientists from all around Read more…
SIBS is the international conference on Image-Based Screening
The leading lights in drug discovery research across pharma, biotech, academia and the vendor community !
Come and visit us at in-cosmetics, the meeting of the major groups of cosmetics, Porte de Versailles in Paris.
« Phenotypic Drug Discovery with High Content Screening » by Permin Elmer
Here is an interesting video from Department of Biological Sciences, University of Notre Dame, explaining how to do imaging on zebrafish embryos.
This article highlights the value of high-content imaging in GPCR drug discovery efforts and emphasize the value of a multiassay approach to study pharmacological properties of compounds of interest.